EXHIBIT I
JOINT FILING AGREEMENT
----------------------
In accordance with Rule 13d-1(k)(1) promulgated under the Securities
Exchange Act of 1934, the undersigned agree to the joint filing of a Statement
on Schedule 13D (including any and all amendments thereto) with respect to the
Common Stock, $0.01 par value, of Miravant Medical Technologies, and further
agree to the filing of this agreement as an Exhibit thereto. In addition, each
party to this Agreement expressly authorizes each other party to this Agreement
to file on its behalf any and all amendments to such Statement on Schedule 13D.
Dated: February 26, 1999
PHARMACIA & UPJOHN COMPANY
By: /s/ Xxx X. Xxxxxxx
------------------------
Title: Secretary
PHARMACIA & UPJOHN S.p.A.
By: /s/ Mats Pettersson
------------------------
Title: Attorney-In-Fact
PHARMACIA & UPJOHN AB
By: /s/ Mats Pettersson
------------------------
Title: Attorney-In-Fact
PHARMACIA & UPJOHN HOLDINGS B.V.
By: /s/ Xxx Xxxxxx
------------------------
Title: Director
PHARMACIA & UPJOHN, INC.
By: /s/ Xxx X. Xxxxxxx
------------------------
Title: Secretary
